Bioblast Pharma Board of Directors Member
Colin Foster served as President and CEO of Bioblast Pharma from January 2015 through June 2016 and as director since January 2015. He has extensive experience in leading therapeutic, diagnostic, and medical device companies in the United States and internationally, working across the R&D-to-commercial continuum. He was the founder and CEO of iSci Management LLC, a life sciences advisory firm, and co-founder and CEO of Optherion, Inc., a venture-backed biologics and diagnostics company targeting ultra-orphan diseases of the immune system and age-related macular degeneration. Prior to that, Mr. Foster was the President and CEO of Bayer Pharmaceuticals Corporation USA and Region Head of the North American Pharmaceuticals business of Bayer AG. Mr. Foster began his post-graduate career with Sandoz Canada Inc. before embarking on an international career with Bayer in Canada, the USA, and Europe.
Mr. Foster has a BSc in Zoology and Microbiology from the University of Toronto, and an MBA from Western University in Canada.Learn about other members of the Board of Directors of Bioblast